Literature DB >> 11166859

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

L Buonaguro1, F M Buonaguro, M L Tornesello, D Mantas, E Beth-Giraldo, R Wagner, S Michelson, M C Prevost, H Wolf, G Giraldo.   

Abstract

The main goal of this study was to investigate a novel approach for an efficient and reproducible production of Virus-Like Particles (VLPs) expressing multiple HIV-1 epitopes. The HIV-1 Pr55(gag)-based VLPs have been produced in a Baculovirus expression system, using a transfer vector able to support the independent expression of different open reading frames (ORFs). In this regard, the gp120 derived from 94UG018 HIV-1(A) isolate, previously studied in our laboratory, has been packaged into the VLPs together with nef and pol ORFs. In particular, the gp120(UG) sequence shows a 90% homology in the V3 region compared to African HIV-1 strains of the A-clade. This novel approach is extremely effective for the production of VLPs expressing all the epitopes, as confirmed by Western Blot characterization. Furthermore, the resulting HIV-VLP(A)s show the expected density (1.14--1.18 g/ml) on a 10--60% sucrose gradient and the morphology of an immature virion at standard transmission electron microscopy. Our results demonstrate that this strategy is highly efficient for expressing a balanced amount of multiple epitopes and their packaging in VLP structures, without affecting the Pr55(gag) autoassembling capacities. Furthermore, the genetic transposition performed in a modified E. coli represents a methodological improvement, allowing a faster and more reproducible identification of recombinant Baculovirus DNA molecules.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11166859     DOI: 10.1016/s0166-3542(00)00136-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  28 in total

1.  Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration.

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Luisa Visciano; Hanne Andersen; Mark Lewis; Ranajit Pal; Maria Lina Tornesello; Ulf Schroeder; Jorma Hinkula; Britta Wahren; Franco M Buonaguro
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

Review 2.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

Authors:  L Buonaguro; M L Tornesello; M Tagliamonte; R C Gallo; L X Wang; R Kamin-Lewis; S Abdelwahab; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Molecular immune signatures of HIV-1 vaccines in human PBMCs.

Authors:  Alessandro Monaco; Francesco M Marincola; Marianna Sabatino; Zoltan Pos; Maria Lina Tornesello; David F Stroncek; Ena Wang; George K Lewis; Franco M Buonaguro; Luigi Buonaguro
Journal:  FEBS Lett       Date:  2009-08-06       Impact factor: 4.124

5.  Potential of equine herpesvirus 1 as a vector for immunization.

Authors:  Sascha Trapp; Jens von Einem; Helga Hofmann; Josef Köstler; Jens Wild; Ralf Wagner; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.

Authors:  L Buonaguro; M L Visciano; M L Tornesello; M Tagliamonte; B Biryahwaho; F M Buonaguro
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Ebola virus-like particles protect from lethal Ebola virus infection.

Authors:  Kelly L Warfield; Catharine M Bosio; Brent C Welcher; Emily M Deal; Mansour Mohamadzadeh; Alan Schmaljohn; M Javad Aman; Sina Bavari
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

8.  Short communication: limited induction of IL-10 in PBMCs from HIV-infected subjects treated with HIV-VLPs.

Authors:  L Buonaguro; M L Tornesello; George K Jewis; F M Buonaguro
Journal:  AIDS Res Hum Retroviruses       Date:  2009-08       Impact factor: 2.205

9.  Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.

Authors:  L Buonaguro; M L Tornesello; R C Gallo; Franco M Marincola; G K Lewis; F M Buonaguro
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

10.  A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.

Authors:  Boyan Grigorov; Valérie Attuil-Audenis; Fabien Perugi; Martine Nedelec; Sarah Watson; Claudine Pique; Jean-Luc Darlix; Hélène Conjeaud; Delphine Muriaux
Journal:  Retrovirology       Date:  2009-03-11       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.